U.S. pharma large copyright scrapped two experimental weight loss tablets very last 12 months—a once-each day pill, lotiglipron, due to elevated liver enzymes and a two times-day by day tablet, danuglipron, due to potent Unwanted effects—but CEO Albert Bourla has stated the company i